Searched for
US DRUG PANEL
How many Americans can afford high-quality healthcare? A new poll finds the number has fallenAmericans face growing challenges affording healthcare. New data reveals a significant drop in those able to manage medical costs and acces...- Stock picks of the week; 5 stocks with consistent score improvement and upside potential of up to 25%Even in normal times it is futile to try and guess the outcome of most global events. But in the New World Order, it makes no sense at all ...
- Govt flags ‘high-risk’ crypto system in note to Parliamentary panelIndia's virtual digital asset sector is now high risk. Intelligence reports reveal extensive illegal activities including drug trafficking ...
- Venezuela soon to become America's 51st state? Here's truth to Donald Trump's shocking remarksDonald Trump has made similar comments about Canada. Rodríguez went on to say that Venezuelan and U.S. officials have been in touch and are...
- UK's FTSE 100 slips as losses in energy stocks and AstraZeneca weighLondon’s FTSE 100 edged lower as losses in energy majors and AstraZeneca weighed on the index amid thin holiday trading. Weak crude prices ...
- What is mifepristone, and why is it used? Court restricts abortion access by blocking mailing of abortion pill in USWhat is mifepristone, and why is it used? A federal appeals court has restricted access to mifepristone by blocking mailing of prescription...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat we are witnessing in the market these days is similar to scenarios that have played out in the past. There have been many points in th...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...
- Resignations and firings have depleted the FBI and Justice Department. They're scrambling to rebuildThe FBI and Justice Department are facing significant staff shortages. To address this, they are lowering hiring requirements and speeding ...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...
- Pharmaceutical logistics in demand as war rattles supply chainsMedicines are vital but useless if lost or spoiled. Pharmaceutical logistics ensures their safe delivery. DHL's Florstadt campus near Frank...
- U.S. FDA reviews Pfizer & Moderna Covid 19 vaccines in young childrenUS health experts' panel will be reviewing the use of covid vaccines in young children on Wednesday. If the committee recommends using covi...
- Final US hurdle for Merck's COVID-19 pill: FDA panel reviewIf authorized, Merck's pill would be the first that U.S. patients could take at home to ease symptoms and speed recovery, a major step towa...
- US Food and Drug Administration panel backs easier home test for HIVExperts have said that a ground -breaking over-the-counter HIV test that can be taken at home is reasonably "safe & effective".
- Experts urge US to restrict drug AvandiaA majority of members of a key advisory committee recommended Wednesday that the US government allow diabetes drug Avandia to stay on the m...
- 'Do not approve Vioxx successor'A painkiller proposed as a successor to Vioxx should not be approved, a panel of federal health advisers overwhelmingly recommended.
- MNCs to pay for data exclusivityFor multinational pharma giants, slowing down the entry of cheaper copies of their new drugs in India may come at a price.
- Drug MNCs may get paid for sharing exclusive dataThe Satwant Reddy panel on drug data exclusivity is now considering a plan to compensate multinational pharmaceutical corporations after de...
- India 'Trips' on MNC drug data exclusivityIn a smart move, an inter-ministerial panel has concluded that slowing down the launch of cheaper copies of the latest pharmaceutical brand...
- Pharma cos seek to take on MNCs' marketing rightsThe domestic pharmaceutical industry has told the Satwant Reddy Panel that local firms should be allowed to challenge MNC drugs’ marketing ...
Load More
